Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7274 p635-639
8 November 2003

News summary

DIARY   Branch meetings   Future Events   Conferences

635 Slow progress with repeat schemes Problems with information technology are continuing to slow progress of the repeat dispensing schemes at pathfinder sites in England ...more

635 SOS group challenges Society over consultation A call has been issued to the Royal Pharmaceutical Society to follow regulatory principles set out by a Government task force as the Society seeks to replace its Royal Charter. The Society believes, however, that it has fulfilled its obligations ...more

636 NHS patients to get easier access to prescriptions National Health Service patients are to be allowed “more flexibility” in obtaining prescription medicines ...more

636 One-third of jobs to go in Department of Health restructuring Staffing levels at the Department of Health are to be cut by over a third by October 2004. Half of the reduction of 1,400 posts will be achieved by job losses, with the other half being transferred to other bodies in the National Health Service ...more

636 English assemblies would have role in raising public health Elected regional assemblies in England will have powers to promote public health in their areas, if they are ever established. However, control of health policy and the National Health Service would remain with the Department of Health ...more

636 Help produced for pharmacies on getting involved with LIFT projects Guidance about how to involve community pharmacies with primary care redevelopment projects, under the National Health Service Local Improvement Finance Trust (LIFT), is being offered to pharmacy owners and pharmaceutical advisers ...more

636 Restart control of entry lobby, urges NPA Community pharmacists are being urged by the National Pharmaceutical Association to reinvigorate local campaigning on control of entry ahead of the 21 November deadline for responses to the Government's “balanced package of measures” ...more

636 Irish “Ask about medicines” Pharmacies in the Republic of Ireland are taking part in a three-month “Ask about your medicines” campaign organised by the Irish Pharmaceutical Union ...more

637 Osteoarthritis pain relieved by leeches Leech therapy appears to improve the symptoms of osteoarthritis and could offer patients an alternative approach to pain relief, a new study reveals ...more

637 Major outbreaks of measles likely soon Unless vaccine uptake improves rapidly major measles epidemics are likely in the United Kingdom this winter, according to Dr Simon Murch, Royal Free and University College medical school, London ...more

637 New osteoporosis drug launched A new drug for osteoporosis, teriparatide (Forsteo), the active fragment of human parathyroid hormone, was launched this week ...more

637 Tobacco regulatory authority call Eleven charities and other bodies with an interest in health have called on the Government to set up a tobacco regulatory authority ...more

638 Lycopene supplements may not be enough to lower prostate cancer risk Men who want to reduce their risk of developing prostate cancer by altering their diet should eat tomatoes or tomato products rather than rely on lycopene supplements, suggest researchers from Ohio State University, Columbus ...more

638 Patients find information leaflets for skin conditions lack detail Information leaflets provided by dermatology departments in the United Kingdom lack sufficient detail, a survey of 259 patients has revealed ...more

638 Management of viral wheeze pre-school needs re-evaluation Guidelines that suggest parents should be provided with a course of oral steroids as part of the management plan for their child's asthma need to be re-evaluated, say researchers. Their recommendation comes after they found no clear benefit of a short course of parent-initiated oral prednisolone for viral wheeze in young children ...more


Research and Development

639 Treatment predictor for breast cancer under development A new test to predict which breast cancer patients will benefit from drugs such as tamoxifen and anastrozole (Arimidex) has been developed ...more

639 New approach to SERM resistant breast tumours Low levels of oestrogen may shrink breast tumours that have developed resistance to tamoxifen and raloxifene, say Chicago researchers ...more

639 Ximelagatran continues to show promise as anticoagulation agent Promising results from two clinical trials of a new anticoagulant were published last month in The New England Journal of Medicine ...more

639 Mixed results for cannabis in MS Cannabinoids could be used to improve patients' mobility and pain control in multiple sclerosis, say researchers ...more

639 Predictable dose for insulin inhaler Regular insulin delivered via the Aerodose insulin inhaler will provide a “pharmacologically predictable” dose of insulin similar to that observed following subcutaneous injection ...more

639 New receptor for sex hormones Identification of a new receptor for the regulation of sex hormone secretion has been reported by Paradigm Therapeutics ...more

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal